Schepens Eye Research Institute - Click to return to home page

Meredith Gregory-Ksander

Current Publications

  1. Hohlbaum, A.M., M.S. Gregory , S-T. Ju, and A. Marshak-Rothstein. Fas-Ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors. J. Immunol. 2001; 167: 6217-6224.

  2. Gregory, M.S ., A.C. Repp, A.M. Hohlbaum, R.R. Saff, A Marshak-Rothstein, and B.R. Ksander. Membrane Fas Ligand Activates Innate Immunity and Terminates Ocular Immune Privilege. . J. Immunol . 2002; 169(5): 2727-2735.

  3. Mo, J-S, M.G. Anderson, M.S. Gregory, R.S. Smith, O.V. Savinova, D.V. Serreze, B.R Ksander, J.W. Streilein, and S.W.M. John. Altering Ocular Immune Privilege, Bone Marrow-derived Cells Pathogenically Contribute to DBA/2J Pigmentary Glaucoma. J. Exp. Med . 2003; 197: 1335-1344.

  4. Carlson, E.C., C-Y. Liu, X Yang, M.S. Gregory , B.R. Ksander, J Drazba, and V.L. Perez. In vivo gene delivery and visualization of corneal stromal cells using an adenoviral vector and keratocyte specific promoter. Invest. Ophthalmol. Vis. Sci. 2004; 45(7): 2194-2200.

  5. Gregory, MS , S. Koh, E. Huang, R.R. Saff, A Marshak-Rothstein, S. Mukai, and B.R. Ksander. A novel treatment for ocular tumors using membrane Fas ligand vesicles to activate innate immunity and terminate immune privilege. Invest. Ophthalmol. Vis. Sci. 2005; 46(7): 2495-2502.

  6. Gregory, MS , R. Saff. A Marshak-Rothstein, and B.R. Ksander. Cleaving of Fas ligand within the eye promotes tumor escape. J. Immunol . Submitted, 2005.

SEO by Artio